Lymphoproliferative disorders are heterogeneous and complex and can be very challenging to characterize. However, the molecular characterization of the different entities carried out in recent years has revealed characteristic mutational profiles associated with the different lymphoma subtypes.
In this on-demand webinar, Dr. Gerard Frigola, hematopathologist at the Hospital Clinic Barcelona, provides some background on lymphoid malignancies and discusses the benefits of using NGS for the analysis of lymphoma samples.
He also shares his experience with the new Ion AmpliSeq Liverpool Lymphoid Network Panel, an NGS community panel designed by leading clinical researchers for fast and comprehensive lymphoid molecular testing. He discusses the panel design, introduces the Liverpool Lymphoid community network, and shares compelling analytical data from his lab to demonstrate the impact of NGS for lymphoid malignancy research.
Speakers:
Gerard Frigola, MD
Hematopathologist
Hospital Clinic, IDIBAPS,
University of Barcelona
For Research Use Only. Not for use in diagnostic procedures.
Please fill out the short form below to view the webinar.
(*Indicates a mandatory field)